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Nicolau’s syndrome: A rare but preventable iatrogenic 
disease
Dear editor,
Nicolau’s syndrome, also called embolia cutis 
medicamentosa or livedoid dermatitis, is a rare injec-
tion site reaction characterized by immediate intense 
pain at the injection site followed by erythema and a 
hemorrhagic patch with a livedoid reticular pattern 
after injections of non-steroidal anti-inflammatory 
drugs (NSAiDS), antiepileptics, antibiotics, antihis-
taminics, corticosteroids, etc. (1). to the best of our 
knowledge, only one case of Nicolau’s syndrome has 
been reported after the use of triamcinolone aceton-
ide. herein we report two cases of Nicolau’s syndrome 
caused by intramuscular injections of triamcinolone 
acetonide and diclofenac sodium, respectively.
CASE 1
A 24-year-old male patient presented with severe 
pain and bluish discoloration of the right arm for 2 
days, which he had noticed shortly after receiving an 
intramuscular injection of triamcinolone for recurrent 
episodes of urticaria by a local practitioner in the right 
deltoid region. on examination, there was a livedoid 
pattern of non-blanchable, violaceous discoloration 
extending from the deltoid area to the distal third of 
the forearm with associated induration (Figure 1, a, 
b). the local area was warm and tender to the touch. 
there was no regional lymphadenopathy, and the rest 
of the examination was normal. the patient’s plate-
let count, bleeding and clotting times, prothrombin 
time, and international normalized ratio (iNr) were 
unremarkable. there was no previous history of any 
bleeding disorder. the patient denied any intake of 
drugs like aspirin, warfarin, etc. Subsequently, the pa-
tient developed an ulcer on the forearm, which was 
managed by topical and systemic antibiotics to pre-
vent any secondary infection of the wound.
CASE 2
A 40-year-old female patient presented with 
complaints of pain and discoloration of the left glu-
teal region after receiving an intramuscular injection 
Figure 1. (a, b) Livedoid, violaceous discoloration of the right forearm in the first case.
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of diclofenac sodium for her arthralgia. A large ec-
chymotic patch with reticular borders was found on 
the gluteal region, extending to the lateral aspect of 
thigh (Figure 2). it was tender to the touch, non-in-
durated, and the local temperature was raised. there 
was no regional lymphadenopathy. No other abnor-
mality was detected on examination. All routine in-
vestigations were within normal limits. Platelet count, 
bleeding, clotting and prothrombin times, and inter-
national normalized ratio (iNr) were within normal 
limits. the lesions resolved within few weeks without 
any complications.
Nicolau syndrome was first described in the early 
1920s by Freudenthal and Nicolau as an adverse ef-
fect of using intramuscular injections of bismuth salts 
in the treatment of syphilis. Since then, several case 
reports of this disease occurring after intramuscular, 
intra-articular, intravenous, and subcutaneous injec-
tions have appeared in the literature associated with 
a variety of drugs like NSAiDs, vitamin K, penicillin, 
antihistamines, corticosteroids, local anesthetics, 
vaccines, polidocanol, and pegylated interferon al-
pha (1).
the pathogenesis of Nicolau syndrome is un-
known, though intra and periarterial injection of 
the drug is a possible cause. Stimulation of the sym-
pathetic nerve due to periarterial injection causes 
spasms and consequent ischemia. inadvertent intra-
arterial injections may cause emboli and occlusion. A 
lipophilic drug may penetrate the vessel and produce 
physical occlusion like fat embolism. Cytotoxic drugs 
may produce perivascular inflammation and ischemic 
necrosis. NSAiDs are believed to additionally induce 
ischemic necrosis due to their inhibition of cyclooxy-
genase and, consequently, prostaglandins (2).
the clinical features of the disease have been di-
vided into three phases in a review by Kim et al. (3). 
the authors describe an initial phase characterized 
by intense pain with subsequent erythema. this is 
followed 1-3 days later by an acute phase, when an 
indurated, tender plaque with livedoid pattern de-
velops. the final phase occurs between 5 days and 2 
weeks later. Necrosis ensues in this stage, with pos-
sible ulceration. 
Diagnosis is chiefly clinical, and histopathology 
shows necrotic changes and vascular thrombosis. 
however, a biopsy was not performed in our cases be-
cause both lesions were painful. Management strate-
gies are variable and range from conservative manage-
ment with analgesics and antibiotics to active surgical 
debridement (4). Complications include deformities, 
contractures or even death. the patient in our first case 
developed ulceration which healed normally, while the 
second case resolved without any complications.
Nicolau syndrome can be avoided by precau-
tions such as aspirating the needle before injecting 
to check for blood, use of Z-track injection technique, 
proper site of injection, avoiding large doses at a sin-
gle site, and regular change of sites if multiple injec-
tions are to be given (5).
Nicolau syndrome is a rare disease. there are a few 
case reports of it occurring after diclofenac injection 
(1-5). We could only find one case report of this syn-
drome after intramuscular injection (iM) of triamcino-
lone in a patient with lichen planus (3), and our case is 
the second reported case of this syndrome as a result 
of triamcinolone acetonide injection, which adds to 
the significance to the present article.
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Figure 2. A large violaceus patch with reticular borders on 
the left gluteal region in Case 2.
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